Clopidogrel resistance: myth or reality? (Q28218055)

Journal of Cardiovascular Pharmacology and Therapeutics

Europe PubMed Central

title

Clopidogrel resistance: myth or reality? (English)

0 references

1 reference

Aron A Barsky

1

0 references

Rohit R Arora

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 2006

0 references

published in

0 references

volume

11

0 references

issue

1

0 references

page(s)

47-53

0 references

cites work

Platelets in atherothrombosis

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Platelet activation and inhibition in unstable coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Platelets and anti-platelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Durability of platelet inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Variability in platelet responsiveness to clopidogrel among 544 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

No change in endothelial-dependent vasomotion late after coronary irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Aspirin resistance in cardiovascular disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Role of antiplatelet drugs in the prevention of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104

Clopidogrel resistance: a new chapter in a fast-moving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840601100104